Long-term treatment with interleukin-1beta induces insulin resistance in murine and human adipocytes
about
GPRC5B activates obesity-associated inflammatory signaling in adipocytesA Potential Role for Pro-Inflammatory Cytokines in the Development of Insulin Resistance in HorsesFat in flames: influence of cytokines and pattern recognition receptors on adipocyte lipolysisMifepristone promotes adiponectin production and improves insulin sensitivity in a mouse model of diet-induced-obesityImplication of inflammatory signaling pathways in obesity-induced insulin resistanceAdipose tissue dysfunction and its effects on tumor metabolismMitochondria: diversity in the regulation of the NLRP3 inflammasome.MCP-1 (monocyte chemotactic protein-1)-induced protein, a recently identified zinc finger protein, induces adipogenesis in 3T3-L1 pre-adipocytes without peroxisome proliferator-activated receptor gammaLPS-Enhanced Glucose-Stimulated Insulin Secretion Is Normalized by ResveratrolFatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signalingThe inflammasome NLRs in immunity, inflammation, and associated diseasesCellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistanceNrf2 deficiency in myeloid cells is not sufficient to protect mice from high-fat diet-induced adipose tissue inflammation and insulin resistance.Time-resolved and tissue-specific systems analysis of the pathogenesis of insulin resistance.MyD88-dependent interplay between myeloid and endothelial cells in the initiation and progression of obesity-associated inflammatory diseases.Mechanisms of inflammatory responses in obese adipose tissue.Interactive changes between macrophages and adipocytes.Immune cell-derived cytokines contribute to obesity-related inflammation, fibrogenesis and metabolic deregulation in human adipose tissue.A novel effect of growth hormone on macrophage modulates macrophage-dependent adipocyte differentiation.Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes.Interleukin-1β mediates macrophage-induced impairment of insulin signaling in human primary adipocytes.Functional polymorphism of IL-1 alpha and its potential role in obesity in humans and miceInterleukin-1 beta: a potential link between stress and the development of visceral obesity.Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5.Increased immune cell infiltration of the exocrine pancreas: a possible contribution to the pathogenesis of type 1 diabetes.Thrap3 docks on phosphoserine 273 of PPARγ and controls diabetic gene programming.Zfp423 promotes adipogenic differentiation of bovine stromal vascular cellsRegulation of fat specific protein 27 by isoproterenol and TNF-α to control lipolysis in murine adipocytes.Genetic determinants of circulating interleukin-1 receptor antagonist levels and their association with glycemic traits.Interleukin-1β regulates fat-liver crosstalk in obesity by auto-paracrine modulation of adipose tissue inflammation and expandability.Interleukin-33 induces protective effects in adipose tissue inflammation during obesity in mice.Inflammasome activation in obesity-related inflammatory diseases and autoimmunity.Fish oil rich diet in comparison to saturated fat rich diet offered protection against lipopolysaccharide-induced inflammation and insulin resistance in miceAdipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease.Interleukin-1beta is a positive regulator of TIARP/STAMP2 gene and protein expression in adipocytes in vitro.Macrophage recruitment in obese adipose tissueAdipocytokine profile, cytokine levels and foxp3 expression in multiple sclerosis: a possible link to susceptibility and clinical course of disease.Lack of interleukin-1 receptor I (IL-1RI) protects mice from high-fat diet-induced adipose tissue inflammation coincident with improved glucose homeostasis.Implication of low level inflammation in the insulin resistance of adipose tissue at late pregnancyTargeting orphan nuclear receptors for treatment of metabolic diseases and autoimmunity
P2860
Q24304291-EE3BFE84-EF25-4877-9E9D-8647EC6198F5Q27026242-A5BD4123-04AE-41A5-A1AF-BCEDC7812369Q27027464-E8A49C92-B695-4010-AB8E-FC4AC6830AE8Q27302419-0B40FE45-C60D-413E-BADC-821EB86B36D6Q27500365-22F82EA0-0E0C-40C3-957C-CD4FCD518007Q28080748-44B0670F-E80A-4208-B4A5-F95BF3858408Q28389465-B14494D6-BDA5-4A25-B21A-7687670DBE45Q28506501-36487366-2B20-4BD0-86E2-F60C1AB87FDBQ28552277-B564AF69-2270-461A-A536-5AB9AE885E2FQ29616024-F7889979-5864-4FD5-BE13-0888A8A12CBCQ29616025-C59B594E-8CB2-4C7A-9B06-697B0FF7174CQ30009848-53F27417-D29B-4AE9-98B3-AD64AD41F8C1Q30419533-30A95692-1D1D-4738-B360-FD067940DE91Q33526310-775E83FA-A952-4AEF-952A-ECBBC037B077Q33569870-0516863D-3AC6-47E5-B0DC-71F189543AF0Q33699810-C437F790-B6E7-4F94-AECD-611E8E3FDD6FQ33768617-7EC98A39-489F-452E-8FF9-39A0EA5F53D0Q33774339-D24062F1-D391-4232-847A-988B0B0FD6A4Q33848254-D6B6FA27-45E0-4A31-8156-11B7AC08486DQ33918445-777BAC0E-83ED-43A5-A908-A6430815AF22Q34001345-40B0BC4D-96BC-4B19-8636-2BC7810587E2Q34117664-28321EA5-111E-4EAE-B7A5-F68172AEC0DFQ34318738-642586FC-CC79-4484-AFED-EB44AFBA6567Q34330155-281E8092-8666-4D81-B916-567F8CCC5DC7Q34393311-922045C0-93B6-4B8E-B33F-FB162C922FECQ34430709-3E765A8D-0900-47B6-8C0F-B3A7D3C0B9F1Q34448278-37223D8E-E374-4B03-8446-E2A0120230A9Q34503345-76E9E360-0DC0-4B65-95C1-A5AD329872A7Q34545454-A695C851-4C5D-4657-8805-9D42209F0C3BQ34558529-46400CBA-8CCC-4B59-9BA5-BFA2003FA43AQ34626217-6DE81C8E-1F66-455F-8EB8-ACF70340CB34Q34701729-841A5881-2C6D-49AC-89CF-C793C12CB34AQ34732698-31A7C331-3A6A-48B8-8E86-DAB06AE2FF70Q34779049-35143DEF-5628-4EEA-93BB-DAC2B95CAF37Q34963127-3F032E36-7A35-4D13-A837-FF69083A20B6Q35007836-C6E447F8-32FF-4A76-AB73-B3244AD5DD60Q35009543-7C91B79E-1C3C-485C-83DA-8FA818738C3DQ35043422-2384F10D-228B-4158-90AA-D8361F9A8AB0Q35417015-B644B71E-1FC5-4CD5-A406-D2C4590E4520Q35714622-B276A21C-BEF9-421B-90B7-ADC74D0984AC
P2860
Long-term treatment with interleukin-1beta induces insulin resistance in murine and human adipocytes
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Long-term treatment with inter ...... in murine and human adipocytes
@ast
Long-term treatment with inter ...... in murine and human adipocytes
@en
Long-term treatment with inter ...... in murine and human adipocytes
@en-gb
Long-term treatment with inter ...... in murine and human adipocytes
@nl
type
label
Long-term treatment with inter ...... in murine and human adipocytes
@ast
Long-term treatment with inter ...... in murine and human adipocytes
@en
Long-term treatment with inter ...... in murine and human adipocytes
@en-gb
Long-term treatment with inter ...... in murine and human adipocytes
@nl
prefLabel
Long-term treatment with inter ...... in murine and human adipocytes
@ast
Long-term treatment with inter ...... in murine and human adipocytes
@en
Long-term treatment with inter ...... in murine and human adipocytes
@en-gb
Long-term treatment with inter ...... in murine and human adipocytes
@nl
P2093
P921
P3181
P1433
P1476
Long-term treatment with inter ...... in murine and human adipocytes
@en
P2093
A Quignard-Boulangé
J-P Bastard
P2860
P2888
P304
P3181
P356
10.1007/S00125-006-0335-Z
P407
P577
2006-07-25T00:00:00Z
P5875
P6179
1039882096